Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

1 results about "Phage display" patented technology

Phage display is a laboratory technique for the study of protein–protein, protein–peptide, and protein–DNA interactions that uses bacteriophages (viruses that infect bacteria) to connect proteins with the genetic information that encodes them. In this technique, a gene encoding a protein of interest is inserted into a phage coat protein gene, causing the phage to "display" the protein on its outside while containing the gene for the protein on its inside, resulting in a connection between genotype and phenotype. These displaying phages can then be screened against other proteins, peptides or DNA sequences, in order to detect interaction between the displayed protein and those other molecules. In this way, large libraries of proteins can be screened and amplified in a process called in vitro selection, which is analogous to natural selection.

Anti-human GPC3 monoclonal antibody

ActiveCN110627904AGood water solubilityImprove patienceImmunoglobulins against cell receptors/antigens/surface-determinantsAntibody ingredientsImmunotherapyPhage display
The invention discloses an anti-human GPC3 monoclonal antibody which is a specific high-affinity nanometer antibody developed by using human GPC3 as a target on the basis of a phage display technology. Compared with the prior art, the anti-human GPC3 monoclonal antibody is successfully prepared; the antibody has high specificity and high affinity, and can be combined with the human GPC3 expressedon the cell surfaces; and the anti-human GPC3 monoclonal antibody belongs to potential medicine for tumor immunotherapy.
Owner:NANJING BLUE SHIELD BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products